Weekly Research Analysts’ Ratings Changes for Establishment Labs (ESTA)

A number of firms have modified their ratings and price targets on shares of Establishment Labs (NASDAQ: ESTA) recently:

  • 11/25/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/19/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/14/2025 – Establishment Labs had its price target raised by analysts at BTIG Research from $70.00 to $81.00. They now have a “buy” rating on the stock.
  • 11/13/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
  • 11/6/2025 – Establishment Labs had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $71.00. They now have an “overweight” rating on the stock.
  • 11/6/2025 – Establishment Labs had its price target raised by analysts at Canaccord Genuity Group Inc. from $60.00 to $72.00. They now have a “buy” rating on the stock.
  • 11/6/2025 – Establishment Labs had its price target raised by analysts at Needham & Company LLC from $48.00 to $70.00. They now have a “buy” rating on the stock.
  • 11/6/2025 – Establishment Labs had its price target raised by analysts at Mizuho from $70.00 to $85.00. They now have an “outperform” rating on the stock.
  • 11/5/2025 – Establishment Labs had its price target raised by analysts at BTIG Research from $62.00 to $70.00. They now have a “buy” rating on the stock.
  • 10/19/2025 – Establishment Labs was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating.
  • 10/11/2025 – Establishment Labs was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating.
  • 10/8/2025 – Establishment Labs had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
  • 10/7/2025 – Establishment Labs had its “neutral” rating reaffirmed by analysts at Citigroup Inc..

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.

Featured Stories

Receive News & Ratings for Establishment Labs Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.